BGI Genomics Raises $300 Million in Private Placement

BGI Genomics of Shenzhen raised almost $300 million for its next-gen sequencing services and genetic tests for medical institutions in a private placement. The company, which has been a major supplier of COVID-19 tests to global markets, raised capital to expand capacity and develop new products. Traditionally, it has focused on prenatal screening, hereditary cancer screening, testing for rare disease and precision medicine research. BGI Genomics is a part of BGI Group, one of the world’s largest genomics organizations. More details.... Stock Symbols: (SHZ: 300676) Share this with colleagues: // //
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.